How and why should we detect ANCA?

Area of Science:

• Immunology
• Nephrology
• Rheumatology

Background:

• Antineutrophil cytoplasmic antibodies (ANCA) are vital diagnostic markers for systemic vasculitis.
• ANCA testing is particularly important for patients with unexplained renal insufficiency.
• The presence of ANCA guides decisions regarding immunosuppressive therapy.

Purpose of the Study:

• To review the diagnostic utility of ANCA testing in various clinical settings.
• To discuss the primary antigens and preferred assay methods for ANCA detection.
• To highlight the evolving role of ANCA in patient management and future diagnostic advancements.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) is preferred for detecting antibodies against proteinase 3 (PR3) and myeloperoxidase (MPO).
• Indirect immunofluorescence (IIF) is used for identifying other ANCA specificities in conditions like inflammatory bowel disease and arthritis.
• Evaluation of the clinical significance of various ANCA specificities.

Main Results:

• Positive ANCA results strongly indicate systemic vasculitis and predict response to immunosuppression.
• Negative ANCA results almost entirely rule out systemic vasculitis.
• While PR3 and MPO are key antigens in renal vasculitis, other ANCA specificities have questionable clinical value.

Conclusions:

• ANCA testing, particularly for PR3 and MPO, is essential for diagnosing renal vasculitis and guiding treatment.
• ELISA is the preferred method for detecting antibodies against PR3 and MPO.
• Future developments in assay techniques and epitope mapping promise improved ANCA diagnostics and patient monitoring.